MD Anderson Therapeutics Discovery team identifies and advances a drug that targets metabolic vulnerability and impairs cancer cell growth and survival
Credit: MD Anderson Cancer Center HOUSTON - A drug discovered and advanced by The University of Texas MD Anderson Cancer Center's Institute for Applied Cancer...








